NDC 58368-013

Veive CBD Pain and Cramps

Apis Mellifica, Arnica Montana, Belladonna, Bryonia Alba, Cimicifuga Racemosa, Cyclymen Europaeum, Joanesia Asoca, Kali Carbonicum, Lilium Tigrinum, Rhamnus Californica, Sabina Bellis Perennis, Cactus Grandiflorus, Caulophyllum Thalictroides, Colocynthis, Gelsemium Sempervirens, Viburnum Opulus, Tilia Europaea

Veive CBD Pain and Cramps is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Biolyte Laboratories, Llc. The primary component is Bryonia Alba Root; Saraca Indica Bark; Atropa Belladonna; Caulophyllum Thalictroides Root; Selenicereus Grandiflorus Stem; Juniperus Sabina Leafy Twig; Apis Mellifera; Arnica Montana; Cyclamen Purpurascens Tuber; Potassium Carbonate; Lilium Lancifolium Whole Flowering; Black Cohosh; Citrullus Colocynthis Fruit Pulp; Gelsemium Sempervirens Root; Tilia X Europaea Flower; Viburnum Opulus Bark; Frangula Californica Bark; Bellis Perennis.

Product ID58368-013_b3b14568-6869-ac2e-e053-2a95a90a36f3
NDC58368-013
Product TypeHuman Otc Drug
Proprietary NameVeive CBD Pain and Cramps
Generic NameApis Mellifica, Arnica Montana, Belladonna, Bryonia Alba, Cimicifuga Racemosa, Cyclymen Europaeum, Joanesia Asoca, Kali Carbonicum, Lilium Tigrinum, Rhamnus Californica, Sabina Bellis Perennis, Cactus Grandiflorus, Caulophyllum Thalictroides, Colocynthis, Gelsemium Sempervirens, Viburnum Opulus, Tilia Europaea
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2020-11-16
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameBioLyte Laboratories, LLC
Substance NameBRYONIA ALBA ROOT; SARACA INDICA BARK; ATROPA BELLADONNA; CAULOPHYLLUM THALICTROIDES ROOT; SELENICEREUS GRANDIFLORUS STEM; JUNIPERUS SABINA LEAFY TWIG; APIS MELLIFERA; ARNICA MONTANA; CYCLAMEN PURPURASCENS TUBER; POTASSIUM CARBONATE; LILIUM LANCIFOLIUM WHOLE FLOWERING; BLACK COHOSH; CITRULLUS COLOCYNTHIS FRUIT PULP; GELSEMIUM SEMPERVIRENS ROOT; TILIA X EUROPAEA FLOWER; VIBURNUM OPULUS BARK; FRANGULA CALIFORNICA BARK; BELLIS PERENNIS
Active Ingredient Strength4 [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 58368-013-01

5 g in 1 PACKET (58368-013-01)
Marketing Start Date2020-11-16
NDC Exclude FlagN
Sample Package?Y

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.